Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Stumpf

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Genetics & Development|May 6, 2011
The cancerous translation apparatusCraig R Stumpf, Davide Ruggero
Methods in Enzymology|February 14, 2009
Chapter 14. Analysis of RNA-protein interactions using a yeast three-hybrid systemCraig R Stumpf, Laura Opperman, Marvin Wickens
RNA (New York, N.Y.)|June 27, 2008
A Caenorhabditis elegans PUF protein family with distinct RNA binding specificityCraig R Stumpf, Judith Kimble, Marvin Wickens
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
Investigating Myc-dependent translational regulation in normal and cancer cellsJohn T Cunningham, Michael Pourdehnad, Craig R Stumpf, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
A 5' cytosine binding pocket in Puf3p specifies regulation of mitochondrial mRNAsDeyu Zhu, Craig R Stumpf, Joseph M Krahn, et al.
Molecular Cell|October 15, 2013
The translational landscape of the mammalian cell cycleCraig R Stumpf, Melissa V Moreno, Adam B Olshen, et al.
Bioinformatics (Oxford, England)|September 20, 2013
Assessing gene-level translational control from ribosome profilingAdam B Olshen, Andrew C Hsieh, Craig R Stumpf, et al.
Cell|May 3, 2011
Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterningNadya Kondrashov, Aya Pusic, Craig R Stumpf, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 2, 2020
A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in MiceTarjani Shukla, June Bryan de la Peña, John M Perish, et al.
Frontiers in Oncology|December 13, 2021
Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven TumorsAdina Gerson-Gurwitz, Nathan P Young, Vikas K Goel, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Genetics & Development|May 6, 2011
The cancerous translation apparatusCraig R Stumpf, Davide Ruggero
Methods in Enzymology|February 14, 2009
Chapter 14. Analysis of RNA-protein interactions using a yeast three-hybrid systemCraig R Stumpf, Laura Opperman, Marvin Wickens
RNA (New York, N.Y.)|June 27, 2008
A Caenorhabditis elegans PUF protein family with distinct RNA binding specificityCraig R Stumpf, Judith Kimble, Marvin Wickens
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
Investigating Myc-dependent translational regulation in normal and cancer cellsJohn T Cunningham, Michael Pourdehnad, Craig R Stumpf, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
A 5' cytosine binding pocket in Puf3p specifies regulation of mitochondrial mRNAsDeyu Zhu, Craig R Stumpf, Joseph M Krahn, et al.
Molecular Cell|October 15, 2013
The translational landscape of the mammalian cell cycleCraig R Stumpf, Melissa V Moreno, Adam B Olshen, et al.
Bioinformatics (Oxford, England)|September 20, 2013
Assessing gene-level translational control from ribosome profilingAdam B Olshen, Andrew C Hsieh, Craig R Stumpf, et al.
Cell|May 3, 2011
Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterningNadya Kondrashov, Aya Pusic, Craig R Stumpf, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 2, 2020
A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in MiceTarjani Shukla, June Bryan de la Peña, John M Perish, et al.
Frontiers in Oncology|December 13, 2021
Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven TumorsAdina Gerson-Gurwitz, Nathan P Young, Vikas K Goel, et al.
Pageof 2